| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | Acoustic differentiation and behavioral response reveals cryptic species within Buergeria treefrogs (Anura, Rhacophoridae) from Taiwan | Wang Y.-H.; Hsiao Y.-W.; Lee K.-H.; Tseng H.-Y.; Lin Y.-P.; Komaki S.; Lin S.-M.; HUI-YUN TSENG | PLoS ONE | 19 | 18 | |
| 2014 | The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis | Chen C.-Y.; Yang S.-C.; Lee K.-H.; Yang X.; Wei L.-Y.; LU-PING CHOW ; Wang T.-C.V.; Hong T.-M.; Lin J.-C.; Kuan C.; PAN-CHYR YANG | Journal of Medicinal Chemistry | 22 | 21 | |
| 2009 | Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents | Yang X.; Shi Q.; Liu Y.-N.; Zhao G.; Bastow K.F.; Lin J.-C.; Yang S.-C.; PAN-CHYR YANG ; Lee K.-H. | Journal of Medicinal Chemistry | 42 | 40 | |
| 2011 | Antitumor agents 283. Further elaboration of Desmosdumotin C analogs as potent antitumor agents: Activation of spindle assembly checkpoint as possible mode of action | Nakagawa-Goto K.; Wu P.-C.; Bastow K.F.; Yang S.-C.; SUNG-LIANG YU ; Chen H.-Y.; Lin J.-C.; Goto M.; Morris-Natschke S.L.; PAN-CHYR YANG ; Lee K.-H. | Bioorganic and Medicinal Chemistry | 17 | 15 | |
| 2011 | Antitumor agents 288: Design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents | Yang X.; Shi Qian; Yang S.-C.; Chen C.-Y.; SUNG-LIANG YU ; Bastow K.F.; Morris-Natschke S.L.; Wu P.-C.; Lai C.-Y.; Wu T.-S.; Pan S.-L.; Teng C.-M.; Lin J.-C.; PAN-CHYR YANG ; Lee K.-H. | Journal of Medicinal Chemistry | 35 | 35 | |
| 2020 | Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study | Lee M.S.; Ryoo B.-Y.; CHIH-HUNG HSU ; Numata K.; Stein S.; Verret W.; Hack S.P.; Spahn J.; Liu B.; Abdullah H.; Wang Y.; He A.R.; Lee K.-H.; Bang Y.-J.; Bendell J.; Chao Y.; Chen J.-S.; Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU ; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N. | The Lancet Oncology | 280 | 256 | |
| 2010 | Cardiac glycosides from antiaris toxicaria with potent cardiotonic activity | Shi L.-S.; Liao Y.-R.; MING-JAI SU ; Lee A.-S.; Kuo P.-C.; Damu A.G.; Kuo S.-C.; Sun H.-D.; Lee K.-H.; Wu T.-S. | Journal of Natural Products | 48 | 40 | |
| 2007 | CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression | Wang S.-W.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; Tsai A.-C.; Chang Y.-L.; JIH-HWA GUH ; Kuo S.-C.; Lee K.-H.; Teng C.-M. | Cancer Letters | 23 | 22 | |
| 2008 | CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo | Wang S.-W.; Pan S.-L.; Huang Y.-C.; JIH-HWA GUH ; Chiang P.-C.; Huang D.-Y.; Kuo S.-C.; Lee K.-H.; Teng C.-M. | Molecular Cancer Therapeutics | 64 | 58 | |
| 2019 | Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG ; ANN-LII CHENG ; YEN-SHEN LU ; Asian Breast Cancer Cooperative Group | Journal of the National Cancer Institute | 61 | 57 | |
| 2013 | Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects | Lai C.-Y.; Pan S.-L.; Yang X.-M.; Chang L.-H.; Chang Y.-L.; PAN-CHYR YANG ; Lee K.-H.; Teng C.-M. | Carcinogenesis | 8 | 8 | |
| 2009 | Ginkgolide B induces apoptosis via activation of JNK and p21-activated protein kinase 2 in mouse embryonic stem cells | Hsuuw Y.-D.; Kuo T.-F.; Lee K.-H.; Liu Y.-C.; Huang Y.-T.; Lai C.-Y.; TZONG-FU KUO ; TZONG-FU KUO | Annals of the New York Academy of Sciences | 8 | 5 | |
| 2022 | HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis | Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN ; YEN-SHEN LU ; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. | BMC Medicine | 24 | 21 | |
| 2015 | Intra-Colonial Functional Differentiation-Related Modulation of the Cellular Membrane in a Pocilloporid Coral Seriatopora caliendrum | Tang C.-H.; Ku P.-C.; CHING-YU LIN ; Chen T.-H.; Lee K.-H.; Lee S.-H.; Wang W.-H. | Marine Biotechnology | 11 | 10 | |
| 2010 | Isolation of therapeutically functional mouse bone marrow mesenchymal stem cells within 3 h by an effective single-step plastic-adherent method | Hsiao F.S.-H.; Cheng C.-C.; Peng S.-Y.; Huang H.-Y.; Lian W.-S.; Jan M.-L.; Fang Y.-T.; Cheng E.C.-H.; Lee K.-H.; Cheng W.T.-K.; Lin S.-P.; SHINN-CHIH WUet al. ; SHAU-PING LIN | Cell Proliferation | 34 | 28 | |
| 2018 | Norepinephrine Administration Is Associated with Higher Mortality in Dialysis Requiring Acute Kidney Injury Patients with Septic Shock | Chen, Ying-Ying; VIN-CENT WU ; Huang, Wei-Chieh; YU-CHANG YEH ; Wu, Mai-Szu; Huang, Chiu-Ching; Wu, Kwan-Dun; Fang, Ji-Tseng; Wu, Chih-Jen; SHUEI-LIONG LIN ; TAI-SHUAN LAI ; YU-FENG LIN ; I-JUNG TSAI ; CHUN-FU LAI ; TAO-MIN HUANG ; Chu T.-S.; YUNG-MING CHEN ; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; FAN-CHI CHANG ; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group | Journal of clinical medicine | 13 | 10 | |
| 2018 | Opsin gene expression regulated by testosterone level in a sexually dimorphic lizard | Tseng W.-H.; Lin J.-W.; Lou C.-H.; Lee K.-H.; Wu L.-S.; Wang T.-Y.; Wang F.-Y.; Irschick D.J.; Lin S.-M.; LEANG-SHIN WU | Scientific Reports | 5 | 5 | |
| 2021 | Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial | Kudo M.; Lim H.Y.; ANN-LII CHENG ; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. | Liver Cancer | 25 | 22 | |
| 2020 | Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors | Desai J.; Deva S.; Lee J.S.; CHIA-CHI LIN ; Yen C.-J.; Chao Y.; Keam B.; Jameson M.; Hou M.-M.; Kang Y.-K.; Markman B.; Lu C.-H.; Rau K.-M.; Lee K.-H.; Horvath L.; Friedlander M.; Hill A.; Sandhu S.; Barlow P.; Wu C.-Y.; Zhang Y.; Liang L.; Wu J.; Paton V.; Millward M. | Journal for ImmunoTherapy of Cancer | 60 | 60 | |
| 2009 | Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-κB pathways | Lin J.-C.; Yang S.-C.; Hong T.-M.; SUNG-LIANG YU ; Qian S.; Linyi W.; Chen H.-Y.; PAN-CHYR YANG ; Lee K.-H. | Journal of Medicinal Chemistry | 52 | 50 | |
